A University of South Australia team has developed a weekly biodegradable injection of levodopa and carbidopa, offering seven-day release to ease dosing and boost adherence for Parkinson’s patients.
A first-in-patient trial using AAV-based OTOF gene therapy, led by Karolinska Institutet and Chinese hospitals, restored hearing (improving from 106 dB to 52 dB) in 10 individuals aged 1–24.
A new global study reveals that people diagnosed with dementia are living longer than before, thanks to earlier diagnosis and advancements in care that reduce the risk of death post-diagnosis.
The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.
A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe epidermolysis bullosa, reducing pain and improving quality of life.
Jonathan Reid, Research and Education Lead at Deafblind UK, explores deafblindness and calls for greater awareness and support for those living with dual-sensory loss.
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
A recent study from the University of Gothenburg has discovered that two existing medications can effectively treat alcohol use disorder, reducing both alcohol consumption and cravings.
